KRAS and adenocarcinoma: To eliminate the impact of SSN on DESCT quantitative parameters, and since the KRAS mutation adenocarcinoma are all SN as well, we deleted imaging data of SSN and then compared the difference between the two groups (KRAS n = 12 to EGFR n = 44).